Ovulation induction is based on the administration of gonadotropins in order to enhance fertility. Daily administration of the drug causes a supra-physiological increase in serum FSH leading to the recruitment of a larger cohort of follicles, further causes their growth and development, and finally, triggering ovulation of usually more than one follicle. In IVF programs, the stimulation process...

INTRODUCTION Ovarian cancer is the cause of a high case-fatality ratio, and most of the cases are diagnosed in late stages. OBJECTIVES To determine the histopathological types, age distribution, and ovarian tumour stages among diagnosed with ovarian cancer at Al - Amal Tower a multi-referral polyclinic of Radiology & Isotope Center Khartoum (RICK), Sudan. METHODS All histopathology reports ...

objective: this study was conducted with the aim to investigate and compare iranian produced and foreign oxytocin for use in induction of labor. materials and methods: this random clinical trial was conducted on a population of 198 pregnant women with live fetus and cephalic presentation and conditions conducive to induction of labor, monitored by obstetricians and gynecologists. they were rand...

Epidemiologic evidence shows that the risk of ovarian cancer is decreased following childbirth. We examined the time points when the decreased risk of postpartum maternal ovarian cancer reaches the lowest point and whether the protective effect diminishes over time. A case-control study nested within the Swedish Fertility Register included 10,086 cases of epithelial ovarian cancer recorded in t...

Cyclin-dependent kinase 5 (CDK5) is a cytoplasmic serine/ threonine kinase. Knockdown of CDK5 enhances paclitaxel sensitivity in human ovarian cancer cells. This study explores the mechanisms by which CDK5 regulates paclitaxel sensitivity in human ovarian cancers. Multiple ovarian cancer cell lines and xenografts were treated with CDK5 small interfering RNA (siRNA) with or without paclitaxel to...

background: ovarian hyperstimulation syndrome (ohss) is a recognized complication of ovulation induction, occurring in 1-10% of ivf and embryo transfer cycles. while mild ohss is of no clinical relevance, severe ohss is a life threatening complication. however, the efficacy of prevalent treatments appeared to be limited. we developed a continuous autotransfusion system with an ultrafiltration i...